基于信息学的评估:原发性甲状旁腺功能亢进症管理中的系统级机会
这项回顾性队列研究在大型学术医疗系统内纳入3151例持续性高钙血症门诊患者,发现仅48%检测了血清PTH,其中90%确诊为经典或正常激素型原发性甲状旁腺功能亢进症(PHPT)。在确诊PHPT的患者中,骨密度评估和手术干预率均很低,存在显著的管理差距。
要点
- 持续性高钙血症患者中仅48%检测了PTH,确诊PHPT者中仅20%评估了骨密度。
- 确诊经典或正常激素型PHPT者中67%符合手术共识标准,但仅15%接受甲状旁腺切除术。
- 信息学工具可提示对持续性高钙血症患者检测PTH,以缩小诊疗差距。
核心结论
- 在大型学术医疗系统中,超过一半的持续性高钙血症患者未评估PHPT,包括许多已有骨病患者。
- 骨密度评估及药物或手术治疗方面的护理差距,错失了避免PHPT骨骼及其他并发症的机会。
研究设计与样本
- 回顾性队列研究,纳入三级学术医疗系统门诊持续性高钙血症患者3151例,分为经典或正常激素型PHPT。
主要发现
- 3151例持续性高钙血症患者中,1526例(48%)检测了PTH,其中1377例(90%)确诊为经典(49%)或正常激素型(41%)PHPT。
- 伴有骨量减少或骨质疏松的高钙血症患者中,65%检测了PTH(P < .001)。
- 中位随访2年时,275例(20%)PHPT患者评估了骨密度(P = .003);50岁及以上经典PHPT女性中,95例(19%)进行了BMD评估。
- 经典或正常激素型PHPT患者中,919例(67%)符合手术共识标准,但仅143例(15%)接受甲状旁腺切除术。
关键数值与推荐
- 持续性高钙血症患者中PTH检测率为48%。
- 确诊PHPT患者中,符合手术共识标准的比例为67%,接受甲状旁腺切除术的比例为15%。
临床怎么用
- 对持续性高钙血症患者应常规检测血清PTH以识别PHPT。
- 确诊PHPT后应评估骨密度,并评估是否符合手术或药物治疗指征。
局限性
- 回顾性研究设计可能受数据完整性影响。
- 单中心学术医疗系统结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Primary hyperparathyroidism (PHPT), a leading cause of hypercalcemia and secondary osteoporosis, is underdiagnosed. OBJECTIVE: This work aims to establish a foundation for an electronic medical record-based intervention that would prompt serum parathyroid hormone (PTH) assessment in patients with persistent hypercalcemia and identify care gaps in their management. METHODS: A retrospective cohort study was conducted in a tertiary academic health system of outpatients with persistent hypercalcemia, who were categorized as having classic or normohormonal PHPT. Main outcome measures included the frequencies of serum PTH measurement in patients with persistent hypercalcemia, and their subsequent workup with bone mineral density (BMD) assessment, and ultimately, medical therapy or parathyroidectomy. RESULTS: Among 3151 patients with persistent hypercalcemia, 1526 (48%) had PTH measured, of whom 1377 (90%) were confirmed to have classic (49%) or normohormonal (41%) PHPT. PTH was measured in 65% of hypercalcemic patients with osteopenia or osteoporosis (P < .001). At median 2-year follow-up, bone density was assessed in 275 (20%) patients with either variant of PHPT (P = .003). Of women aged 50 years or older with classic PHPT, 95 (19%) underwent BMD assessment. Of patients with classic or normohormonal PHPT, 919 patients (67%) met consensus criteria for surgical intervention, though only 143 (15%) underwent parathyroidectomy. CONCLUSION: Within a large academic health system, more than half of patients with confirmed hypercalcemia were not assessed for PHPT, including many patients with preexisting bone disease. Care gaps in BMD assessment and medical or surgical therapy represent missed opportunities to avoid skeletal and other complications of PHPT.
引用
- Dawood NB, Tseng CH, Nguyen DT, et al. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment. J Clin Endocrinol Metab. 2021. PMID: 34313755. doi:10.1210/clinem/dgab540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。